3rd Quarter - Report

CAPITOL COUNSEL LLC for ASTRAZENECA PHARMACEUTICALS, LP

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health care reform; drug safety, pricing and reimbursement; comparative effectiveness; proposed revisions to 340B program, including implementation of related provisions in comprehensive health care reform: P.L. 111-148, Patient Protection and Affordable Care Act and P.L. 111-152, Health Care and Education Reconciliation Act; Changes to outpatient 340B prescription drug program in HR 4213, American Jobs and Closing Tax Loopholes Act, and draft Senate amendments, and S.3793, Job Creation and Tax Cuts Act.

LobbyistCovered position, as disclosed
CATHERINE FINLEY —
SHANNON FINLEY —
SARA FRANKO —
DREW GOESL —
JAMES GOULD —
DENISE HENRY MORRISEY —
DAVID JONES —
JAMES O MCCRERY New Committee Member, Joint Cmte on Taxation
JOHN D RAFFAELLI —
RICHARD LYLES SULLIVAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4213 (111th), S. 3793 (111th)

Medicare/Medicaid MMM

Medicare and Medicaid coverage, coding and reimbursement of pharmaceuticals; Medicare Part D coverage gap and discount program, rebates for Medicare and Medicaid dual-eligibles, including implementation of related provisions in comprehensive health care reform: P.L. 111-148, Patient Protection and Affordable Care Act and P.L. 111-152, Health Care and Education Reconciliation Act

LobbyistCovered position, as disclosed
CATHERINE FINLEY —
SHANNON FINLEY —
SARA FRANKO —
DREW GOESL —
JAMES GOULD —
DENISE HENRY MORRISEY —
DAVID JONES —
JAMES O MCCRERY New Committee Member, Joint Cmte on Taxation
JOHN D RAFFAELLI —
RICHARD LYLES SULLIVAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.